Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Report 2023

Report ID: 857568 | Published Date: Apr 2026 | No. of Page: 147 | Base Year: 2025 | Rating: 4.8
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Recombinant Human Granulocyte Colony-Stimulating Market Overview
    1.1 Recombinant Human Granulocyte Colony-Stimulating Product Scope
    1.2 Recombinant Human Granulocyte Colony-Stimulating Segment by Type
        1.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016 & 2021 & 2027)
        1.2.2 Lenograstim (Granocyte)
        1.2.3 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
        1.2.4 Others
    1.3 Recombinant Human Granulocyte Colony-Stimulating Segment by Application
        1.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Chemotherapy Induced Neutropenia
        1.3.3 Before Blood Donation
        1.3.4 Stem Cell Transplants
        1.3.5 Others
    1.4 Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Recombinant Human Granulocyte Colony-Stimulating Price Trends (2016-2027)

2 Recombinant Human Granulocyte Colony-Stimulating Estimates and Forecasts by Region
    2.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Recombinant Human Granulocyte Colony-Stimulating Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2016-2021)
        2.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2016-2021)
    2.3 Global Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Recombinant Human Granulocyte Colony-Stimulating Estimates and Projections (2016-2027)
        2.4.2 Europe Recombinant Human Granulocyte Colony-Stimulating Estimates and Projections (2016-2027)
        2.4.3 China Recombinant Human Granulocyte Colony-Stimulating Estimates and Projections (2016-2027)
        2.4.4 Japan Recombinant Human Granulocyte Colony-Stimulating Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Estimates and Projections (2016-2027)
        2.4.6 India Recombinant Human Granulocyte Colony-Stimulating Estimates and Projections (2016-2027)
3 Global Recombinant Human Granulocyte Colony-Stimulating Competition Landscape by Players
    3.1 Global Top Recombinant Human Granulocyte Colony-Stimulating Players by Sales (2016-2021)
    3.2 Global Top Recombinant Human Granulocyte Colony-Stimulating Players by Revenue (2016-2021)
    3.3 Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Human Granulocyte Colony-Stimulating as of 2020)
    3.4 Global Recombinant Human Granulocyte Colony-Stimulating Average Price by Company (2016-2021)
    3.5 Manufacturers Recombinant Human Granulocyte Colony-Stimulating Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Type
    4.1 Global Recombinant Human Granulocyte Colony-Stimulating Historic Market Review by Type (2016-2021)
        4.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2016-2021)
        4.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type (2016-2021)
        4.1.3 Global Recombinant Human Granulocyte Colony-Stimulating Price by Type (2016-2021)
    4.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Type (2022-2027)
        4.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Type (2022-2027)
        4.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Price Forecast by Type (2022-2027)
5 Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Application
    5.1 Global Recombinant Human Granulocyte Colony-Stimulating Historic Market Review by Application (2016-2021)
        5.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2016-2021)
        5.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application (2016-2021)
        5.1.3 Global Recombinant Human Granulocyte Colony-Stimulating Price by Application (2016-2021)
    5.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Application (2022-2027)
        5.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Application (2022-2027)
        5.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Price Forecast by Application (2022-2027)

6 North America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures
    6.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales by Company
        6.1.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales by Company (2016-2021)
        6.1.2 North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2016-2021)
    6.2 North America Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type
        6.2.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2016-2021)
        6.2.2 North America Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2022-2027)
    6.3 North America Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application
        6.3.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application (2016-2021)
        6.3.2 North America Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application (2022-2027)

7 Europe Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures
    7.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Company
        7.1.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Company (2016-2021)
        7.1.2 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2016-2021)
    7.2 Europe Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type
        7.2.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2022-2027)
    7.3 Europe Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application
        7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)

8 China Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures
    8.1 China Recombinant Human Granulocyte Colony-Stimulating Sales by Company
        8.1.1 China Recombinant Human Granulocyte Colony-Stimulating Sales by Company (2016-2021)
        8.1.2 China Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2016-2021)
    8.2 China Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type
        8.2.1 China Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2016-2021)
        8.2.2 China Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2022-2027)
    8.3 China Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application
        8.3.1 China 313 Sales Breakdown by Application (2016-2021)
        8.3.2 China 313 Sales Breakdown by Application (2022-2027)

9 Japan Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures
    9.1 Japan Recombinant Human Granulocyte Colony-Stimulating Sales by Company
        9.1.1 Japan Recombinant Human Granulocyte Colony-Stimulating Sales by Company (2016-2021)
        9.1.2 Japan Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2016-2021)
    9.2 Japan Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type
        9.2.1 Japan Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2022-2027)
    9.3 Japan Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures
    10.1 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales by Company
        10.1.1 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales by Company (2016-2021)
        10.1.2 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2016-2021)
    10.2 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type
        10.2.1 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application
        10.3.1 Southeast Asia KG Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia KG Sales Breakdown by Application (2022-2027)

11 India Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures
    11.1 India Recombinant Human Granulocyte Colony-Stimulating Sales by Company
        11.1.1 India Recombinant Human Granulocyte Colony-Stimulating Sales by Company (2016-2021)
        11.1.2 India Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2016-2021)
    11.2 India Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type
        11.2.1 India Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2016-2021)
        11.2.2 India Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Type (2022-2027)
    11.3 India Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application
        11.3.1 India Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application (2016-2021)
        11.3.2 India Recombinant Human Granulocyte Colony-Stimulating Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Recombinant Human Granulocyte Colony-Stimulating Business
    12.1 Amgen
        12.1.1 Amgen Corporation Information
        12.1.2 Amgen Business Overview
        12.1.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Amgen Recombinant Human Granulocyte Colony-Stimulating Products Offered
        12.1.5 Amgen Recent Development
    12.2 Qilu Pharmaceutical
        12.2.1 Qilu Pharmaceutical Corporation Information
        12.2.2 Qilu Pharmaceutical Business Overview
        12.2.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Products Offered
        12.2.5 Qilu Pharmaceutical Recent Development
    12.3 Shijiazhuang Pharmaceutical
        12.3.1 Shijiazhuang Pharmaceutical Corporation Information
        12.3.2 Shijiazhuang Pharmaceutical Business Overview
        12.3.3 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Products Offered
        12.3.5 Shijiazhuang Pharmaceutical Recent Development
    12.4 Kyowa Hakko Kirin
        12.4.1 Kyowa Hakko Kirin Corporation Information
        12.4.2 Kyowa Hakko Kirin Business Overview
        12.4.3 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Products Offered
        12.4.5 Kyowa Hakko Kirin Recent Development
    12.5 Gensci
        12.5.1 Gensci Corporation Information
        12.5.2 Gensci Business Overview
        12.5.3 Gensci Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Gensci Recombinant Human Granulocyte Colony-Stimulating Products Offered
        12.5.5 Gensci Recent Development
    12.6 Amoytop Biotech
        12.6.1 Amoytop Biotech Corporation Information
        12.6.2 Amoytop Biotech Business Overview
        12.6.3 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Products Offered
        12.6.5 Amoytop Biotech Recent Development
    12.7 Hangzhou Jiuyuan
        12.7.1 Hangzhou Jiuyuan Corporation Information
        12.7.2 Hangzhou Jiuyuan Business Overview
        12.7.3 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Products Offered
        12.7.5 Hangzhou Jiuyuan Recent Development
    12.8 Huaxin
        12.8.1 Huaxin Corporation Information
        12.8.2 Huaxin Business Overview
        12.8.3 Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Huaxin Recombinant Human Granulocyte Colony-Stimulating Products Offered
        12.8.5 Huaxin Recent Development
    12.9 Triprime
        12.9.1 Triprime Corporation Information
        12.9.2 Triprime Business Overview
        12.9.3 Triprime Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Triprime Recombinant Human Granulocyte Colony-Stimulating Products Offered
        12.9.5 Triprime Recent Development
    12.10 Sinovac
        12.10.1 Sinovac Corporation Information
        12.10.2 Sinovac Business Overview
        12.10.3 Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Sinovac Recombinant Human Granulocyte Colony-Stimulating Products Offered
        12.10.5 Sinovac Recent Development
    12.11 Zhaoke
        12.11.1 Zhaoke Corporation Information
        12.11.2 Zhaoke Business Overview
        12.11.3 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Products Offered
        12.11.5 Zhaoke Recent Development
    12.12 Kawin
        12.12.1 Kawin Corporation Information
        12.12.2 Kawin Business Overview
        12.12.3 Kawin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Kawin Recombinant Human Granulocyte Colony-Stimulating Products Offered
        12.12.5 Kawin Recent Development

13 Recombinant Human Granulocyte Colony-Stimulating Manufacturing Cost Analysis
    13.1 Recombinant Human Granulocyte Colony-Stimulating Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Recombinant Human Granulocyte Colony-Stimulating
    13.4 Recombinant Human Granulocyte Colony-Stimulating Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Recombinant Human Granulocyte Colony-Stimulating Distributors List
    14.3 Recombinant Human Granulocyte Colony-Stimulating Customers

15 Market Dynamics
    15.1 Recombinant Human Granulocyte Colony-Stimulating Market Trends
    15.2 Recombinant Human Granulocyte Colony-Stimulating Drivers
    15.3 Recombinant Human Granulocyte Colony-Stimulating Market Challenges
    15.4 Recombinant Human Granulocyte Colony-Stimulating Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Recombinant Human Granulocyte Colony-Stimulating Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Recombinant Human Granulocyte Colony-Stimulating Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Recombinant Human Granulocyte Colony-Stimulating Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Region (2016-2021)
    Table 5. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2016-2021)
    Table 6. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Region (2016-2021)
    Table 8. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) Forecast by Region (2022-2027)
    Table 9. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) of Key Companies (2016-2021)
    Table 13. Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Company (2016-2021)
    Table 14. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Company (2016-2021)
    Table 16. Global Recombinant Human Granulocyte Colony-Stimulating by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Granulocyte Colony-Stimulating as of 2020)
    Table 17. Global Recombinant Human Granulocyte Colony-Stimulating Average Price (USD/g) of Key Company (2016-2021)
    Table 18. Manufacturers Recombinant Human Granulocyte Colony-Stimulating Manufacturing Sites and Area Served
    Table 19. Manufacturers Recombinant Human Granulocyte Colony-Stimulating Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Type (2016-2021)
    Table 22. Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Type (2016-2021)
    Table 23. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Recombinant Human Granulocyte Colony-Stimulating Price (USD/g) by Type (2016-2021)
    Table 25. Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Type (2022-2027)
    Table 26. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Type (2022-2027)
    Table 28. Global Recombinant Human Granulocyte Colony-Stimulating Price (USD/g) by Type (2022-2027)
    Table 29. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Application (2016-2021) 
    Table 30. Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Application (2016-2021)
    Table 31. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Recombinant Human Granulocyte Colony-Stimulating Price (USD/g) by Application (2016-2021)
    Table 33. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Application (2022-2027)
    Table 34. Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Application (2022-2027)
    Table 35. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Application (2022-2027)
    Table 37. Global Recombinant Human Granulocyte Colony-Stimulating Price (USD/g) by Application (2022-2027)
    Table 38. North America Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Company (2016-2021)
    Table 39. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Company (2016-2021)
    Table 40. North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Company (2016-2021)
    Table 42. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016-2021) & (KG)
    Table 43. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2016-2021)
    Table 44. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2022-2027) & (KG)
    Table 45. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2022-2027)
    Table 46. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2016-2021) & (KG)
    Table 47. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2016-2021)
    Table 48. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2022-2027) & (KG)
    Table 49. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2022-2027)
    Table 50. Europe Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Company (2016-2021)
    Table 51. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Company (2016-2021)
    Table 52. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Company (2016-2021)
    Table 54. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016-2021) & (KG)
    Table 55. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2016-2021)
    Table 56. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2022-2027) & (KG)
    Table 57. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2022-2027)
    Table 58. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2016-2021) & (KG)
    Table 59. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2016-2021)
    Table 60. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2022-2027) & (KG)
    Table 61. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2022-2027)
    Table 62. China Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Company (2016-2021)
    Table 63. China Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Company (2016-2021)
    Table 64. China Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Company (2016-2021)
    Table 66. China Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016-2021) & (KG)
    Table 67. China Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2016-2021)
    Table 68. China Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2022-2027) & (KG)
    Table 69. China Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2022-2027)
    Table 70. China Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2016-2021) & (KG)
    Table 71. China Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2016-2021)
    Table 72. China Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2022-2027) & (KG)
    Table 73. China Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2022-2027)
    Table 74. Japan Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Company (2016-2021)
    Table 75. Japan Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Company (2016-2021)
    Table 76. Japan Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Company (2016-2021)
    Table 78. Japan Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016-2021) & (KG)
    Table 79. Japan Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2016-2021)
    Table 80. Japan Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2022-2027) & (KG)
    Table 81. Japan Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2022-2027)
    Table 82. Japan Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2016-2021) & (KG)
    Table 83. Japan Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2016-2021)
    Table 84. Japan Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2022-2027) & (KG)
    Table 85. Japan Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Company (2016-2021)
    Table 87. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016-2021) & (KG)
    Table 91. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2022-2027) & (KG)
    Table 93. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2016-2021) & (KG)
    Table 95. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2022-2027) & (KG)
    Table 97. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2022-2027)
    Table 98. India Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Company (2016-2021)
    Table 99. India Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Company (2016-2021)
    Table 100. India Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Company (2016-2021)
    Table 102. India Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2016-2021) & (KG)
    Table 103. India Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2016-2021)
    Table 104. India Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2022-2027) & (KG)
    Table 105. India Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2022-2027)
    Table 106. India Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2016-2021) & (KG)
    Table 107. India Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2016-2021)
    Table 108. India Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2022-2027) & (KG)
    Table 109. India Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2022-2027)
    Table 110. Amgen Corporation Information
    Table 111. Amgen Description and Business Overview
    Table 112. Amgen Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
    Table 113. Amgen Recombinant Human Granulocyte Colony-Stimulating Product
    Table 114. Amgen Recent Development
    Table 115. Qilu Pharmaceutical Corporation Information
    Table 116. Qilu Pharmaceutical Description and Business Overview
    Table 117. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
    Table 118. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product
    Table 119. Qilu Pharmaceutical Recent Development
    Table 120. Shijiazhuang Pharmaceutical Corporation Information
    Table 121. Shijiazhuang Pharmaceutical Description and Business Overview
    Table 122. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
    Table 123. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product
    Table 124. Shijiazhuang Pharmaceutical Recent Development
    Table 125. Kyowa Hakko Kirin Corporation Information
    Table 126. Kyowa Hakko Kirin Description and Business Overview
    Table 127. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
    Table 128. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Product
    Table 129. Kyowa Hakko Kirin Recent Development
    Table 130. Gensci Corporation Information
    Table 131. Gensci Description and Business Overview
    Table 132. Gensci Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
    Table 133. Gensci Recombinant Human Granulocyte Colony-Stimulating Product
    Table 134. Gensci Recent Development
    Table 135. Amoytop Biotech Corporation Information
    Table 136. Amoytop Biotech Description and Business Overview
    Table 137. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
    Table 138. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Product
    Table 139. Amoytop Biotech Recent Development
    Table 140. Hangzhou Jiuyuan Corporation Information
    Table 141. Hangzhou Jiuyuan Description and Business Overview
    Table 142. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
    Table 143. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Product
    Table 144. Hangzhou Jiuyuan Recent Development
    Table 145. Huaxin Corporation Information
    Table 146. Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
    Table 147. Huaxin Description and Business Overview
    Table 148. Huaxin Recombinant Human Granulocyte Colony-Stimulating Product
    Table 149. Huaxin Recent Development
    Table 150. Triprime Corporation Information
    Table 151. Triprime Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
    Table 152. Triprime Description and Business Overview
    Table 153. Triprime Recombinant Human Granulocyte Colony-Stimulating Product
    Table 154. Triprime Recent Development
    Table 155. Sinovac Corporation Information
    Table 156. Sinovac Description and Business Overview
    Table 157. Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
    Table 158. Sinovac Recombinant Human Granulocyte Colony-Stimulating Product
    Table 159. Sinovac Recent Development
    Table 160. Zhaoke Corporation Information
    Table 161. Zhaoke Description and Business Overview
    Table 162. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
    Table 163. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Product
    Table 164. Zhaoke Recent Development
    Table 165. Kawin Corporation Information
    Table 166. Kawin Description and Business Overview
    Table 167. Kawin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
    Table 168. Kawin Recombinant Human Granulocyte Colony-Stimulating Product
    Table 169. Kawin Recent Development
    Table 170. Production Base and Market Concentration Rate of Raw Material
    Table 171. Key Suppliers of Raw Materials
    Table 172. Recombinant Human Granulocyte Colony-Stimulating Distributors List
    Table 173. Recombinant Human Granulocyte Colony-Stimulating Customers List
    Table 174. Recombinant Human Granulocyte Colony-Stimulating Market Trends
    Table 175. Recombinant Human Granulocyte Colony-Stimulating Market Drivers
    Table 176. Recombinant Human Granulocyte Colony-Stimulating Market Challenges
    Table 177. Recombinant Human Granulocyte Colony-Stimulating Market Restraints
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Recombinant Human Granulocyte Colony-Stimulating Product Picture
    Figure 2. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application in 2021 & 2027
    Figure 6. Chemotherapy Induced Neutropenia Examples
    Figure 7. Before Blood Donation Examples
    Figure 8. Stem Cell Transplants Examples
    Figure 9. Others Examples
    Figure 10. Global Recombinant Human Granulocyte Colony-Stimulating Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 12. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) Growth Rate (2016-2027)
    Figure 13. Global Recombinant Human Granulocyte Colony-Stimulating Price Trends Growth Rate (2016-2027) (USD/g)
    Figure 14. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region: 2016 VS 2021
    Figure 15. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region: 2021 VS 2027
    Figure 16. North America Recombinant Human Granulocyte Colony-Stimulating Revenue (Million USD) Growth Rate (2016-2027)
    Figure 17. North America Recombinant Human Granulocyte Colony-Stimulating Sales (KG) Growth Rate (2016-2027)
    Figure 18. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue (Million USD) Growth Rate (2016-2027)
    Figure 19. Europe Recombinant Human Granulocyte Colony-Stimulating Sales (Million USD) Growth Rate (2016-2027)
    Figure 20. China Recombinant Human Granulocyte Colony-Stimulating Revenue (Million USD) Growth Rate (2016-2027)
    Figure 21. China Recombinant Human Granulocyte Colony-Stimulating Sales (Million USD) and Growth Rate (2016-2027)
    Figure 22. Japan Recombinant Human Granulocyte Colony-Stimulating Revenue (Million USD) Growth Rate (2016-2027)
    Figure 23. Japan Recombinant Human Granulocyte Colony-Stimulating Sales (Million USD) Growth Rate (2016-2027)
    Figure 24. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Revenue (Million USD) Growth Rate (2016-2027)
    Figure 25. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales (Million USD) Growth Rate (2016-2027)
    Figure 26. India Recombinant Human Granulocyte Colony-Stimulating Revenue (Million USD) Growth Rate (2016-2027)
    Figure 27. India Recombinant Human Granulocyte Colony-Stimulating Sales (Million USD) Growth Rate (2016-2027)
    Figure 28. Global 5 Largest Recombinant Human Granulocyte Colony-Stimulating Players Market Share by Revenue in Recombinant Human Granulocyte Colony-Stimulating: 2016 & 2020
    Figure 29. Recombinant Human Granulocyte Colony-Stimulating Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 30. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Type (2016-2021)
    Figure 31. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate by Type in 2016 & 2020
    Figure 32. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Application (2016-2021)
    Figure 33. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate by Application in 2016 & 2020
    Figure 34. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type in 2020
    Figure 35. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application in 2020
    Figure 36. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type in 2020
    Figure 37. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application in 2020
    Figure 38. China Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type in 2020
    Figure 39. China Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application in 2020
    Figure 40. Japan Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type in 2020
    Figure 41. Japan Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application in 2020
    Figure 42. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type in 2020
    Figure 43. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application in 2020
    Figure 44. India Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type in 2020
    Figure 45. India Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application in 2020
    Figure 46. Key Raw Materials Price Trend
    Figure 47. Manufacturing Cost Structure of Recombinant Human Granulocyte Colony-Stimulating 
    Figure 48. Manufacturing Process Analysis of Recombinant Human Granulocyte Colony-Stimulating
    Figure 49. Recombinant Human Granulocyte Colony-Stimulating Industrial Chain Analysis
    Figure 50. Channels of Distribution
    Figure 51. Distributors Profiles
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation 
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
Qilu Pharmaceutical
Shijiazhuang Pharmaceutical
Kyowa Hakko Kirin
Gensci
Amoytop Biotech
Hangzhou Jiuyuan
Huaxin
Triprime
Sinovac
Zhaoke
Kawin
Frequently Asked Questions
Recombinant Human Granulocyte Colony-Stimulating report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Recombinant Human Granulocyte Colony-Stimulating report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Recombinant Human Granulocyte Colony-Stimulating report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports